ARGENX Trademark

Trademark Overview


On Wednesday, December 21, 2022, a trademark application was filed for ARGENX with the United States Patent and Trademark Office. The USPTO has given the ARGENX trademark a serial number of 97727259. The federal status of this trademark filing is REGISTERED as of Tuesday, September 3, 2024. This trademark is owned by argenx B.V.. The ARGENX trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system

Wholesale and retail store services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing services and patient information services namely, providing consumer product information in the field of immunology, diseases of the immune system and antibody therapeutics; provision of customer or patient information, namely, providing consumer product information relating to pharmaceutical, medical, healthcare products through an online computer network; administration of patient reimbursement programs

Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and medical information services relating to biopharmaceutical products

Research and development in the field of immunology, antibody engineering and autoimmune diseases; drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research, design, analysis, and testing in the field of immunity, autoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticals, clinical trials, research and development
argenx

General Information


Serial Number97727259
Word MarkARGENX
Filing DateWednesday, December 21, 2022
Status700 - REGISTERED
Status DateTuesday, September 3, 2024
Registration Number7491300
Registration DateTuesday, September 3, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements


Description of MarkThe mark consists of the word "ARGENX" in lowercase in dark gray followed by a V-shaped design, the left segment in dark green and the right segment in green, positioned above a circle in green.
Goods and ServicesPharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
Indication of Colors claimedThe color(s) dark gray, green, and dark green is/are claimed as a feature of the mark.
Goods and ServicesWholesale and retail store services for pharmaceutical preparations in the field of immunology and autoimmune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; marketing services and patient information services namely, providing consumer product information in the field of immunology, diseases of the immune system and antibody therapeutics; provision of customer or patient information, namely, providing consumer product information relating to pharmaceutical, medical, healthcare products through an online computer network; administration of patient reimbursement programs
Goods and ServicesProviding information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; medical consultancy and medical information services relating to biopharmaceutical products
Goods and ServicesResearch and development in the field of immunology, antibody engineering and autoimmune diseases; drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services, namely, research, design, analysis, and testing in the field of immunity, autoimmune diseases and antibody engineering; providing medical and scientific research information in the field of pharmaceuticals, clinical trials, research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 18, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, January 18, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 18, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 18, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Nameargenx B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE

Party Nameargenx B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE

Party Nameargenx B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE

Trademark Events


Event DateEvent Description
Saturday, December 24, 2022NEW APPLICATION ENTERED
Wednesday, January 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 19, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 4, 2023ASSIGNED TO EXAMINER
Tuesday, June 6, 2023NON-FINAL ACTION WRITTEN
Tuesday, June 6, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 19, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 19, 2023SUSPENSION LETTER WRITTEN
Thursday, October 19, 2023LETTER OF SUSPENSION E-MAILED
Thursday, May 16, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 19, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, April 22, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 24, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 15, 2024INQUIRY TO SUSPENSION E-MAILED
Wednesday, May 15, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, May 15, 2024SUSPENSION INQUIRY WRITTEN
Thursday, May 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 10, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 10, 2024ASSIGNED TO PETITION STAFF
Friday, July 12, 2024CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, September 3, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 3, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Tuesday, September 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 3, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, September 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED